Halozyme Therapeutics Inc (NASDAQ:HALO)

26.26
Delayed Data
As of Sep 30
 -0.25 / -0.94%
Today’s Change
12.71
Today|||52-Week Range
29.77
+48.11%
Year-to-Date
Wall Street Breakfast: The Week Ahead
Sep 06 / Seeking Alpha - Paid Partner Content
Stocks To Watch: Tech Reboots And Eyes On Lululemon, Peloton & GameStop
Sep 05 / Seeking Alpha - Paid Partner Content

Today’s Trading

Previous close26.51
Today’s open26.58
Day’s range26.08 - 26.81
Volume45,505
Average volume (3 months)1,161,506
Market cap$3.5B
Data as of 4:00pm ET, 09/30/2020

Growth & Valuation

Earnings growth (last year)+10.53%
Earnings growth (this year)+238.50%
Earnings growth (next 5 years)+56.50%
Revenue growth (last year)+29.06%
P/E ratioNM
Price/Sales13.06
Price/Book38.06

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc-1.05-1.91%
TWSTTwist Bioscience Cor...-2.77-3.52%
FATEFate Therapeutics In...+0.67+1.70%
DNLIDenali Therapeutics ...-0.43-1.18%
Data as of 3:59pm ET, 09/30/2020

Financials

Next reporting dateNovember 10, 2020
EPS forecast (this quarter)$0.20
Annual revenue (last year)$196.0M
Annual profit (last year)-$72.2M
Net profit margin-36.86%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts